LifeCodexx, Elucigene Diagnostics Partner to Offer NIPT in UK and Ireland | GenomeWeb

NEW YORK (GenomeWeb) – LifeCodexx and Elucigene Diagnostics said today that they have partnered to make LifeCodexx's noninvasive prenatal screening test, PrenaTest, available to patients in the UK and Ireland.

Konstanz, Germany based-LifeCodexx launched PrenaTest based on technology it licensed from Sequenom in 2012 and has made the test available throughout Europe. Elucigene Diagnostics, based in Manchester, UK, is a developer and distributor of prenatal and human genetic diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.